Renovaro

PriceRenovaro

RENB

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Historical stock price chart and annual return over the past years

-87%

5 years

% Total

RENB
-34%

5 years

Annual Return

RENB